In 2025, Samuel King, a doctoral student at Stanford University, conducted research exploring the intersection of artificial intelligence and synthetic biology. King utilized a generative AI model to propose genetic blueprints for microscopic viruses, marking a preliminary step in investigating whether AI can be used to design new life forms.

While the project has sparked interest regarding the capabilities of generative models in scientific research, the current scope of the work is limited to the design phase. The research does not involve the actual creation of synthetic life, though the study suggests that such advancements could be a future possibility. The project has prompted discussions within the scientific community regarding the dual-use potential of AI in biology, specifically concerning the ability of algorithms to generate complex genetic information that could theoretically be used to synthesize pathogens.

There is currently no consensus on the regulatory framework required for AI-driven biological design. While some experts argue that these tools accelerate medical breakthroughs, others express concern that the democratization of such technology lowers the barrier for creating harmful biological agents. The MIT Tech Review report focuses on the technical methodology of King’s work, framing it as an inquiry into the limits of generative AI rather than an immediate safety crisis.